我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
30
6 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
已完成
13
43.3%
尚未招募
6
20.0%
招募中
5
16.7%
暂停
1
3.3%
终止
4
13.3%
撤回
暂无批准数据
- The NSW Government has awarded $800,000 in Clinical Trials Fellowship grants to improve cancer clinical trial access for rural and regional patients across the state. - Three grants worth $200,000 each focus on regional initiatives including remote trial delivery frameworks, teletrials, and engagement with underrepresented populations. - A fourth $200,000 grant supports the ACTIvate study for anaplastic thyroid cancer immunotherapy, building on global evidence to address unique treatment challenges. - The funding is part of Cancer Institute NSW's annual $5 million investment in cancer clinical trials, aiming to ensure equitable access regardless of geographic location.
